Farms.com Home   News

Farmer Co-ops Call on Congress to Include Pension Relief to Next COVID-19 Response Package

Farmer Co-ops Call on Congress to Include Pension Relief to Next COVID-19 Response Package

The National Council of Farmer Cooperatives called on Congress to include provisions to provide funding relief to have single-employer pension plans in the next legislative package to address the economic impacts of the COVID-19 pandemic. The call came in a letter sent today to House and Senate leadership.

“Many of the approximately 2,000 farmer cooperatives in the United States continue to provide single-employer pension plan benefits to their employees,” the letter states. “t has been increasingly challenging to fund those benefits in recent years given historically low interest rates…and escalating Pension Benefits Guarantee Corporation (PBGC) premiums. For example, one NCFC member reports that those two factors are leading to a 130% increase in PBGC premiums just this year alone.”

The letter notes that the House-passed Health and Economic Recovery Omnibus Emergency Solutions (HEROES) Act included provisions to address these issues.

Among policies that NCFC letter recommends are:
• Lengthening the amortization period for funding shortfalls from 7 years to 15;
• Extending interest rate stabilization beyond 2020;
• Additional measures such as consideration of lowering PBGC premiums.
“Those provisions would assist businesses such as farmer cooperatives continue to offer pension benefits to their employees without severely draining critical working and investment capital,” the letter concludes.

Click here to see more...

Trending Video

Finding a Balance of Innovation and Regulation - Dr. Peter Facchini

Video: Finding a Balance of Innovation and Regulation - Dr. Peter Facchini

Regulations help markets and industry exist on level playing fields, keeping consumers safe and innovation from going too far. However, incredibly strict regulations can stunt innovation and cause entire industries to wither away. Dr. Peter James Facchini brings his perspective on how existing regulations have slowed the advancement of medical developments within Canada. Given the international concern of opium poppy’s illicit potential, Health Canada must abide by this global policy. But with modern technology pushing the development of many pharmaceuticals to being grown via fermentation, is it time to reconsider the rules?

Dr. Peter James Facchini leads research into the metabolic biochemistry in opium poppy at the University of Calgary. For more than 30 years, his work has contributed to the increased availability of benzylisoquinoline alkaloid biosynthetic genes to assist in the creation of morphine for pharmaceutical use. Dr. Facchini completed his B.Sc. and Ph.D. in Biological Sciences at the University of Toronto before completing Postdoctoral Fellowships in Biochemistry at the University of Kentucky in 1992 & Université de Montréal in 1995.